MannKind to Acquire scPharmaceuticals, Boosting Growth
August 25, 2025
Acquisition expected to diversify and accelerate double-digit revenue growth with FUROSCIX, an innovative treatment for edema due to chronic heart failure and chronic kidney disease,
